Clinical Trials Directory

Trials / Completed

CompletedNCT07169188

A Clinical Study Investigating the Efficacy of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival Health

A 12-Week Randomized, Controlled, Single-Blind, Clinical Study Investigating the Efficacy of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival Health

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
154 (actual)
Sponsor
HALEON · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to evaluate the ability of an experimental toothpaste, containing 0.454 percent (%) Stannous Fluoride (SnF2) to improve gingival health and reduce plaque accumulation compared to a regular fluoride toothpaste (reference dentifrice) in participants with localized, plaque-induced, gingivitis.

Detailed description

This will be a single-center, 12 weeks, randomized, controlled, examiner-blind, 2 treatment arms, parallel group design clinical study to evaluate the efficacy of an experimental toothpaste containing 0.454% SnF2, used twice daily in reducing gingivitis and plaque accumulation in a population with clinically measurable levels of gingivitis. The clinical efficacy of the experimental toothpaste will be compared with a reference dentifrice, a commercially available, regular fluoride toothpaste. Additionally, unstimulated saliva samples will be collected from a sub-set of the randomized participants pre-brushing and at 15, 30, 60 and 120 minutes post-brushing which will be analyzed for tin concentration to investigate the retention of the stannous \[tin (II)\] ion within the oral cavity. Approximately 160 participants will be randomized to ensure approximately 144 evaluable participants complete the study.

Conditions

Interventions

TypeNameDescription
DRUGTest Fluoride ToothpasteToothpaste containing 0.454% SnF2, 0.3% zinc chloride (ZnCl2) and 1% alumina.
DRUGColgate Cavity Protection ToothpasteRegular fluoride toothpaste containing 0.76% sodium monofluorophosphate.

Timeline

Start date
2025-09-09
Primary completion
2025-12-23
Completion
2025-12-23
First posted
2025-09-11
Last updated
2026-01-21

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT07169188. Inclusion in this directory is not an endorsement.